Order Article Reprints

Navarro-Partida J, Altamirano-Vallejo JC, Aceves Franco LA, Gonzalez-Cortes J, Hernandez-Da Mota S, García-Aguirre JG, Azuara-Galindo CD, Castro-Castaneda CR, Armendariz-Borunda J, Santos A. Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration. Pharmaceutics. 2021; 13(9):1491. https://doi.org/10.3390/pharmaceutics13091491

Navarro-Partida, Jose, Juan Carlos Altamirano-Vallejo, Luis Abraham Aceves Franco, Jesús Gonzalez-Cortes, Sergio Hernandez-Da Mota, Jose Gerardo García-Aguirre, Carlos David Azuara-Galindo, Carlos Rodrigo Castro-Castaneda, Juan Armendariz-Borunda, and Arturo Santos. 2021. "Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration" Pharmaceutics 13, no. 9: 1491. https://doi.org/10.3390/pharmaceutics13091491

Navarro-Partida, J., Altamirano-Vallejo, J. C., Aceves Franco, L. A., Gonzalez-Cortes, J., Hernandez-Da Mota, S., García-Aguirre, J. G., Azuara-Galindo, C. D., Castro-Castaneda, C. R., Armendariz-Borunda, J., & Santos, A. (2021). Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration. Pharmaceutics, 13(9), 1491. https://doi.org/10.3390/pharmaceutics13091491